Your SlideShare is downloading. ×
  • Like
California(CA) ACC Annual Meeting: Controversies & Advances in the Treatment of Cardiovascular Disease
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

California(CA) ACC Annual Meeting: Controversies & Advances in the Treatment of Cardiovascular Disease

  • 368 views
Published

 

Published in Health & Medicine
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
368
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
2
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Controversies & Advances in the Treatment of Cardiovascular Disease The Thirteenth in the Series • November 21 & 22, 2013 The Beverly Hills Hotel – Beverly Hills, California Program Directors: Raj Makkar, MD, FACC, P.K. Shah, MD, FACC, Timothy D. Henry, MD, FACC, Alfredo Trento, MD, FACC, Saibal Kar, MD, FACC, John Gordon Harold, MD, MACC, Jon Kobashigawa, MD, FACC, William Bommer, MD, FACC 24TH Annual Meeting of the California ACC Sponsored by: Promedica International in cooperation with the California Chapter of the American College of Cardiology, the British Cardiovascular Society, the California Society of Thoracic Surgeons, the American College of Cardiology Foundation, the American Heart Association, and the International Academy of Cardiology
  • 2. Controversies & Advances in the Treatment of Cardiovascular Disease Program Description We are proud to be celebrating the thirteenth annual Controversies and Advances in the Treatment of Cardiovascular Disease symposium this year! The two-day scientific program will offer realistic views on many controversial issues in cardiovascular disease today. Session topics will include women’s heart disease, imaging, hypertension, cell therapy, STEMI, electrophysiology, adult congenital heart disease, coronary artery disease, aortic valve disease, mitral valve disease, and heart failure therapy. Sessions will include a combination of debates, state-of-the-art lectures, and roundtable discussions. A faculty of internationally known leaders in the field has been invited to share their knowledge and experiences with complex and controversial cases. TARGET AUDIENCE The conference is designed for cardiologists, interventional cardiologists, cardiovascular and thoracic surgeons, perfusionists, nurses, technicians and those involved in the diagnosis, treatment and care of individuals with controversial and complex cases of cardiac disease. CME Accreditation and Designation Promedica International is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Promedica International designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Provider approved by the California Board of Registered Nursing, Provider #8495 for 17.25 Contact Hours. Category 1 CEUs for Perfusionists have been applied for through the American Board of Cardiovascular Perfusion (ABCP). Commercial Support This program is supported in part by educational grants and exhibits from industry, in accordance with the ACCME Standards for Commercial Support. At the time of printing, a complete list of commercial supporters was not available. Appropriate acknowledgement will be given to all supporters in meeting materials onsite.
  • 3. The Thirteenth in the Series • November 21 & 22, 2013 Learning Objectives Upon completion of this course, participants should be able to: : : Discuss and debate imaging modalities for specific disease states and procedures. : : Understand the JNC 2013 report and its implications for prevention, detection, evaluation, and treatment of high blood pressure. : : Evaluate the efficacy of treating women with statins through the lens of the newly released NCEP Guidelines. : : Discuss current controversies in adult congenital heart disease, including complications from repair of Tetralogy of Fallot, and the ideal method for replacing the pulmonary valve. : : Recognize the pathophysiology of mitral regurgitation and compare and contrast medical, interventional, and surgical therapies. : : Understand the controversies and debates surrounding transcatheter aortic valve replacement (TAVR). : : Evaluate current STEMI therapy and controversies in care of acute cardiovascular emergencies. : : Compare and contrast atrial fibrillation treatments and evaluate the role of anticoagulants. call for Abstracts Submissions of original abstracts are being accepted and will be considered for oral presentation and poster display when submitted online at www.promedicacme.com. A Moderated Oral Abstract Session will be held Wednesday, November 20, 2013 from 6:00 – 8:00 PM Deadline for Abstract Submissions: November 8, 2013 Abstract Categories : : Aortic Stenting : : Healthcare Policy : : Aortic Surgery : : Imaging : : Arrhythmias : : Minimally Invasive Surgery : : Atherosclerosis : : Anti-thrombotic Therapy : : Carotid Stenting and Surgery : : Cell Therapy : : Congenital Heart Disease in Adults : : Congestive Heart Failure : : Coronary Surgery : : Drug Eluting Stents : : New Devices: Cardiac Resynchronization, Heart Failure Monitors : : Percutaneous Valve Repair and Replacement : : Stem Cell Therapy : : Valvular Heart Disease : : Other
  • 4. Faculty Program Directors Stephen C. Cook, MD, FACC Subha V. Raman, MD The Ohio State University Columbus, OH Raj Makkar, MD, FACC Children’s Heart Institute of Pittsburgh of UPMC Pittsburgh, PA P.K. Shah, MD, FACC David A. Cox, MD, FACC Timothy D. Henry, MD, FACC Lehigh Valley Hospital Allentown, PA University of California San Francisco San Francisco, CA Anthony DeMaria, MD, MACC Ivan Rokos, MD, FACC Alfredo Trento, MD, FACC Saibal Kar, MD, FACC John Gordon Harold, MD, MACC Jon Kobashigawa, MD, FACC Rita F. Redberg, MD, MSc, FACC UCSD Medical Center San Diego, CA UCLA – Olive View Altadena, CA Vasken Dilsizian, MD, FACC Hartzell V. Schaff, MD, FACC University of Maryland School of Medicine Baltimore, MD Mayo Clinic Rochester, MN Local Faculty Uri Elkayam, MD, FACC Emory University School of Medicine Atlanta, GA Francisco A. Arabia, MD, MBA, FACC C. Noel Bairey Merz, MD, FACC Daniel S. Berman, MD, FACC David S. Cannom, MD, FACC Wen Cheng, MD Sumeet S. Chugh, MD, FACC Lawrence S.C. Czer, MD, FACC Neal Eigler, MD, FACC Fardad Esmailian, MD Ruchira Garg, MD, FACC Hasan Jilaihawi, MD Sanjay Kaul, MD, MPH, FACC Asher Kimchi, MD, FACC Frank Litvack, MD, FACC Eduardo Marbán, MD, PhD, FACC Mamoo Nakamura, MD, FACC Jignesh Patel, MD, PhD, FACC Alistair Phillips, MD Florian Rader, MD, MSc Chrisandra Shufelt, MD, MS, NCMP Robert J. Siegel, MD, FACC Ronald G. Victor, MD, FACC Evan Zahn, MD, FACC Ted Feldman, MD William Bommer, MD, FACC Guest Faculty Matthew J. Budoff, MD, FACC UCLA David Geffen School of Medicine Torrance, CA Alfred E. Buxton, MD, FACC Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA USC Medical Center Los Angeles, CA Evanston Hospital Evanston, IL Michael R. Gold, MD, PhD, FACC MUSC Charleston, SC Howard Hodis, MD Leslee Shaw, PhD, FACC Iain A. Simpson MD, FRCP, FACC, FESC President, British Cardiovascular Society United Kingdom Deepak Srivastava, MD Gladstone Institutions San Francisco, CA University of Southern California Keck School of Medicine Los Angeles, CA Paul Teirstein, MD, FACC Norman M. Kaplan, MD Eric J. Velazquez, MD Scripps Clinic La Jolla, CA University of Texas Southwestern Medical School Dallas, TX Duke University Medical Center Durham, NC Morton J. Kern, MD, FACC Long Beach VA Long Beach, CA St. Paul's Hospital, University of British Columbia Vancouver, Canada Michael J. Mack, MD, FACC David A. Wood, , MB, ChB, MSc Baylor Heart Hospital Plano, TX John G. Webb, MD Imperial College London, United Kingdom Franz H. Messerli, MD, FACC St. Luke’s – Roosevelt Hospital Center New York, NY Lunch Panel Discussion Faculty Todd D. Miller, MD Mayo Clinic Rochester, MN (lunch activities are not included in CME hours) Jeffrey W. Moses, MD, FACC David Brown, MD, FACC Columbia University Medical Center New York, NY Christine Mummery, PhD Leiden University Medical Center Leiden, The Netherlands Jagat Narula, MD, PhD, MACC Mount Sinai New York Mount Sinai School of Medicine New York, NY Patrick T. O’Gara, MD, FACC Brigham and Women's Hospital Boston, MA Douglas L. Packer, MD, FACC Mayo Clinic St. Marys Hospital Rochester, MN Eric N. Prystowsky, MD, FACC St. Vincent’s Hospital Indianapolis, IN The Heart Hospital Baylor Plano Dallas, TX Gregory P. Fontana, MD, FACC Lenox Hill Hospital-NSLIJ New York, NY Michael Garippa SynCardia Systems, Inc. Tucson, AZ Junaid H. Khan, MD East Bay Cardiac Surgery Medical Group Oakland, CA Thomas M. Priselac, MPH Cedars-Sinai Health System Los Angeles, CA Rhonda Robb Medtronic Minneapolis, MN Larry Wood Edwards Lifesciences Irvine, CA
  • 5. Preliminary Scientific Program Wednesday, November 20, 2013 6:00 – 8:00 PM Welcome Reception and Registration Moderated Oral Abstract Session Thursday, November 21, 2013 7:45 – 8:00 AM Welcome Address 8:00 – 9:20 AM SESSION I – Women’s Heart Disease Moderator: C. Noel Bairey Merz, MD, FACC 8:00 – 8:20 AM DEBATE New NCEP Guidelines: Should Women Be Treated with Statins? : : C. Noel Bairey-Merz, MD, FACC : : Rita F. Redberg, MD, MSc, FACC 8:20 – 8:40 AM DEBATE Women and Ischemic Heart Disease: Why Do Women Continue to Face a Higher Mortality? : : C. Noel Bairey Merz, MD, FACC : : Leslee Shaw, PhD, FACC 8:40 – 9:00 AM 9:20 – 10:50 AM 11:45 – 12:10 AM SESSION II – Imaging DEBATE Renal Denervation: Hope or Hype? Moderators: Daniel S. Berman, MD, FACC, and Matthew J. Budoff, MD, FACC 9:20 – 9:35 AM Present and Future of Cardiac Imaging in CAD Daniel S. Berman, MD, FACC 9:35 – 9:50 AM Current Status of CT Scanning in Guiding TAVR Procedures Hasan Jilaihawi, MD 9:50 – 10:10 AM DEBATE Myocardial Viability Testing Effectively Guides Management of the CAD Patient With Low LVEF : : Pro: Vasken Dilsizian, MD, FACC : : Con: Eric J. Velazquez, MD, FACC 10:10 – 10:30 AM DEBATE Coronary CTA Will Replace Most Non-invasive Stress Imaging Procedures : : Pro: Matthew J. Budoff, MD, FACC : : Con: Todd D. Miller, MD 10:30 – 10:50 AM DEBATE MRI Should Guide Decision for ICD Implantation : : Pro: Subha V. Raman, MD, FACC : : Con: Jagat Narula, MD, PhD, MACC DEBATE The KEEPS Trials: Should Women Ever Receive HRT? 10:50 – 11:20 AM : : Howard Hodis, MD : : Chrisandra Shufelt, MD, MS, NCMP 11:20 AM – 12:20 PM 9:00 – 9:20 AM STATE-OF-THE-ART LECTURE Controversies in the Management of Cardiac Disease in Pregnancy Uri Elkayam, MD, FACC Break & Visit Exhibits SESSION III – Hypertension: JNC 8 Ain’t! Moderator: Ronald G. Victor, MD, FACC 11:20 – 11:45 AM DEBATE Resistant Hypertension: Public Enemy #1 or a Non-Issue in the Right Hands? : : Norman M. Kaplan, MD : : Franz H. Messerli, MD, FACC : : Florian Rader, MD : : Ronald G. Victor, MD, FACC 12:10 – 12:20 AM Roundtable Discussion 12:20 – 1:20 PM Lunch (lunch activities are not included in CME hours) Lunch Panel: Obamacare: How Will It Affect Us? Panelists: William Bommer, MD, FACC David Brown, MD, FACC Gregory P. Fontana, MD, FACC John Gordon Harold, MD, MACC Junaid H. Khan, MD Michael Mack, MD, FACC Thomas M. Priselac, MPH Rita Redberg, MD, FACC Paul Teirstein, MD, FACC 1:20 – 1:40 PM STATE-OF-THE-ART LECTURE What Should I Do With All the Antiplatelet/Anticoagulant Medication Available? Sanjay Kaul, MD, MPH, FACC 1:40 – 2:00 PM STATE-OF-THE-ART LECTURE What Worked, What Didn’t and What Holds Promise in Cardiology: An Editor’s Perspective Anthony N. DeMaria, MD, MACC
  • 6. 2:00 – 3:00 PM 4:40 – 5:05 PM 8:30 – 9:00 AM SESSION IV – Controversies in Cell Therapy DEBATE Culprit Only vs. Multivessel PCI in STEMI : : Fix the Culprit and Go Back to Bed! DEBATE Which Anticoagulant for Atrial Fibrillation? Warfarin is Outdated : : Protagonist Paul S. Teirstein, MD, FACC Eric N. Prystowsky, MD, FACC : : Finish the Job! : : Antagonist Jeffrey W. Moses, MD, FACC Douglas L. Packer, MD, FACC 5:05 – 5:30 PM 9:00 – 9:30 AM DEBATE Out of Hospital Cardiac Arrest: To Cath or Not : : Out of My ED and Into Your Cath Lab! DEBATE The Future of the Implantable Defibrillator : : Subcutaneous and Wearable Devices Will Replace the Conventional ICD 2:00 – 2:20 PM Human Pluripotent Stem Cells in Genetic Cardiac Disease: The Model Patient? Christine L. Mummery, PhD 2:20 – 2:40 PM Reprogramming Approaches to Cardiovascular Disease Deepak Srivastava, MD 2:40 – 3:00 PM Can We Attain Meaningful Cardiac Regeneration? Eduardo Marbán, MD, PhD, FACC 3:00 – 3:30 PM Break & Visit Exhibits Ivan Rokos, MD, FACC : : Unnecessary and Dangerous for the Patient, the Doctor and the Hospital Michael R. Gold, MD, PhD, FACC David A. Cox, MD, FACC Alfred E. Buxton, MD, FACC 3:30 – 4:00 PM STATE-OF-THE-ART LECTURE Politics and Medicine David Wood, MB, ChB, MSc 4:00 – 5:30 PM SESSION V – Controversies in STEMI Moderators: Timothy D. Henry, MD, FACC, and Ivan Rokos, MD, FACC 4:00 – 4:15 PM STEMI Therapy in 2013. What We Know and What We Don’t Know! Timothy D. Henry, MD, FACC 4:15 – 4:40 PM DEBATE Radial vs. Femoral for STEMI : : All STEMI Patients, Even Those With Cardiogenic Shock and Out of Hospital Cardiac Arrest Should be Done Radial : : The Conventional ICD is Here to Stay 9:30 – 10:00 AM Friday, November 22, 2013 7:55 – 8:00 AM Welcome Remarks DEBATE Sports Activity and Sudden Cardiac Death : : Screen Young Athletes, that is When it Counts David S. Cannom, MD SESSION VI – Electrophysiology : : Screening for Sudden Death Risk Only Helps the Middle Aged Athlete Moderators: Sumeet S. Chugh MD, FACC, David S. Cannom MD 10:00 – 10:30 AM 8:00 – 10:00 AM Sumeet S. Chugh, MD, FACC Break & Visit Exhibits 8:00 – 8:30 AM DEBATE Current Management of Atrial Fibrillation : : Tailored Ablation Therapies are a Win-win Approach Douglas L. Packer, MD, FACC : : Judicious Use of Drug Therapy Trumps All Other Approaches Eric N. Prystowsky, MD, FACC 10:30– 11:55 PM SESSION VII – Controversies in Adult Congenital Heart Disease The Failing Right Ventricle after Repair of Tetralogy of Fallot 10:30 – 10:45 AM The Scope of the Problem Stephen C. Cook, MD, FACC Morton J. Kern, MD, FACC 10:45 – 11:00 AM : : Femoral is the Preferred Approach Especially for High Risk Patients What Defines a Failing RV and When Should We Intervene? David A. Cox, MD, FACC Ruchira Garg, MD, FACC
  • 7. 11:00 – 11:35 AM 1:00 PM – 2:00 PM 3:00 – 3:12 PM DEBATE What is the Ideal Way to Replace the Pulmonary Valve in Congenital Heart Patients? : : Surgery is the Gold Standard and is the Procedure of Choice SESSION VIII – Controversies in Coronary Artery Disease Anatomy and Pathophysiology of Mitral Regurgitation Moderators: John G. Webb, MD, Michael J. Mack, MD, FACC, and P.K. Shah, MD, FACC Hartzell V. Schaff, MD, FACC 3:12 – 3:24 PM 1:00 – 1:15 PM Ted Feldman, MD, FACC Treatment of Coronary Artery Disease: If Andreas Gruentzig Were Still Alive 3:24 – 3:36 PM Alistair Phillips, MD : : Transcatheter Pulmonary Valve Therapy Has Come of Age and is the Procedure of Choice Evan Zahn, MD, FACC Ted Feldman, MD, FACC : : What Rebuttal? A Collaborative Approach is the Future for These Patients 1:15 – 1:30 PM Alistair Phillips, MD, and Evan Zahn, MD, FACC Treatment of Coronary Artery Disease: If Rene Favoloro Were Still Alive Michael J. Mack, MD, FACC Pearls and Myths of Diagnosis of Mitral Regurgitation Timing of Intervention for Primary MR and Functional MR Patrick T. O’Gara, MD, FACC 3:36 – 3:51 PM Roundtable Discussion 3:51 – 4:03 PM Transcatheter Therapy for Mitral Valve Disease. Is it the Future? 11:35 – 11:45 AM 1:30 – 1:45 PM Mechanical Circulatory Assist Device Therapy for the Congenital Heart When All Else Fails Medical Treatment of Atherosclerosis, From Brown and Goldstein, Discoveries to What the Future Holds Francisco A. Arabia, MD, MBA, FACC Ted Feldman, MD, FACC 11:45 – 11:55 AM 1:45 – 2:00 PM Minimally Invasive Surgery: Is it Really Minimally Invasive? Is it Safe? What Does the Future Hold for Adults Who Have Survived With Congenital Heart Disease? Roundtable Discussion Alfredo Trento, MD, FACC 2:00 PM – 2:45 PM 4:15 – 5:30 PM Jamil Aboulhosn, MD, FACC SESSION IX – Aortic Valve SESSION XI – Controversies in Heart Failure Therapy 11:55 – 1:00 PM Lunch Moderators: John G. Webb, MD, Michael J. Mack, MD, FACC (lunch activities are not included in CME hours) 2:00 – 2:15 PM Lunch Panel: Innovation in an Environment of Changing Healthcare – Will It Survive in America? Moderator: Frank Litvack, MD, FACC Panelists: Gregory P. Fontana, MD, FACC Michael Garippa John G. Webb, MD Michael J. Mack, MD FACC Rita F. Redberg, MD, MSc, FACC Rhonda Robb Larry Wood Saibal Kar, MD, FACC 4:03 – 4:15 PM Moderators: Jon Kobashigawa, MD, FACC, and Francisco A. Arabia, MD, MBA, FACC Transcatheter Aortic Valve Replacement: Promising, but Restraint is Still Needed 4:15 – 4:30 PM Michael J. Mack, MD, FACC Jon Kobashigawa, MD, FACC  2:15 – 2:30 PM Transcatheter Aortic Valve Replacement: The Time for Restraint is Over John G. Webb, MD 2:30 – 2:45 PM Advances in Heart Failure Therapy: Where Are We Now? 4:30 – 5:00 PM DEBATE What is the Optimal Mechanical Therapy for Biventricular Failure? : : TAH Roundtable Discussion Francisco A. Arabia, MD, MBA, FACC 2:45 – 3:00 PM Fardad Esmailian, MD Break & Visit Exhibits 3:00 – 4:15 PM SESSION X – Mitral Valve Moderators: Alfredo Trento, MD, FACC, Saibal Kar, MD, FACC, Robert J. Siegel, MD, FACC : : VAD 5:00 – 5:30 PM DEBATE What is the Future of Biological Therapies for End Stage Heart Disease? : : Xenotransplantation Lawrence S.C. Czer, MD, FACC : : Whole Organ Engineering Jignesh Patel, MD, PhD, FACC November 21 & 22, 2013
  • 8. 24TH Annual Meeting Satellite Events Providing Ongoing Education of Cardiologists and Team Members Available Courses/ Events: Other CA ACC Events: (By Invitation or Your Special Request) Í  ardiology Update: C New Developments 2013 Symposium Wednesday, November 20, 2013 Newport Beach Marriott 2:00 – 6:00 PM Presentations 6:00 – 7:00 PM Reception Course Director Dipti Itchhaporia, MD, FACC Registration: 800-514-4624 or online at http://hoag.org/events All Following Events To Be Held at The Beverly Hills Hotel Í  ardiac Care Associates Educational C Session & Networking Reception Thursday, November 21, 2013 5:30 – 8:30 PM Polo Private Patio, Salon, & Room Í Controversies” Celebration “ & CA ACC Awards Dinner Friday, November 22, 2013 6:30 – 9:30 PM Polo Private Room, Salon & Patio Í  A ACC Board of Directors/ C Foundation/PAC/Committee Meetings Saturday, November 23, 2013 7:30 AM – 2:00 PM Rodeo West Room Elected/Appointed Leaders Breakfast, meetings, lunch – addressing all of the hot topics and challenging issues facing Cardiology in California today. FEATURING: Provider Action for Treating Congenital Hearts (PATCH) presentation and statewide-overview. Í  ellows In Training Educational F Session – What You Don’t Learn In Your Training Program! Saturday, November 23, 2013 9:00 AM – 12:00 PM Polo Private Patio, Salon & Room ALL fellows in training in California are welcome and encouraged to attend at NO COST! Travel and Lodging stipends available! Contact the CA ACC Chapter directly at 1-877-460-5880. CA ACC Members Complimentary, Guests $75. “Controversies” attendees are just $125. Advance Reservations REQUIRED. This event WILL sell out early. Enjoy a memorable night featuring camaraderie and a delectable dinner! Please contact the CA ACC Chapter directly at 1-877-460-5880 to make your reservation for the event. California Chapter of the American College of Cardiology mission: To advocate for accessible, highest quality, cost effective cardiovascular care for Californians. Proud Partner of the
  • 9. Registration Information Refunds $595 Physician/Industry through November 8, 2013 $695 Physician/Industry after  November 8, 2013 $395 Nurse/Resident/Technician through November 8, 2013 $495 Nurse/Resident/Technician after November 8, 2013 $395 ACC National Members  $195 California Chapter ACC Members/ Cardiac Care Associates All cancellations must be submitted in writing, via facsimile or postal mail. Refunds are subject to a $100 administration charge. Cancellations cannot be accepted over the telephone. Refunds will not be available after November 8, 2013. Registration fees include breakfasts, lunches, and welcome reception, as well as scientific program materials. Please make checks payable to Promedica International in U.S. dollars drawn on a U.S. bank. Visa, MasterCard, Discover and American Express credit cards are also accepted. Registrations should be faxed, mailed or submitted online at www.promedicacme.com. To register, please complete the attached form and mail or fax to: Hotel Accommodations A special room rate of $415 per night plus tax at the celebrated Beverly Hills Hotel has been arranged for program participants. Reserve your room prior to the cutoff date of Thursday, October 31, 2013 by calling 1-800-283-8885, or 1-310-276-2251. Mention your affiliation with the Controversies and Advances in the Treatment of Cardiovascular Disease symposium to receive the special rate. Activity Evaluation Evaluation by online questionnaire will address content, presentation, and future educational needs. Promedica International 300 Carlsbad Village Dr., Suite 108A-326 Carlsbad, CA 92008 Tel: (760) 720-2263, Fax: (760) 720-6263 Lsteigerwald@promedicacme.com Controversies & Advances in the Treatment of Cardiovascular Disease November 21 & 22, 2013 • The Beverly Hills Hotel - Beverly Hills, California Visit us at www.promedicacme.com for convenient online registration. Physician/Industry: $595 through November 8, 2013 $695 after November 8, 2013 Nurse/Resident/Technician: $395 through November 8, 2013 $495 after November 8, 2013 ACC National Members: $395  California Chapter ACC Members/Cardiac Care Associates: $195 All fees in US dollars drawn on US banks: P  Check Enclosed P  American Express P Visa/MasterCard      P Discover Credit Card Number Expiration Date Signature P MD   PRN  PCCP  PNP First/Last Name Institution Mailing Address City/State/Zip/Country Telephone Fax Email Address Specialty Please mail or fax to: Promedica International, 300 Carlsbad Village Dr., Suite 108A-326, Carlsbad, CA 92008 Tel: (760) 720-2263, Fax: (760) 720-6263, Lsteigerwald@promedicacme.com
  • 10. : : As always, the “Controversies” committee presented the latest and greatest in cardiovascular research and treatment in a provocative and innovative format. : : Consistently great conference, year after year! : : Exceptional faculty, timely topics, extremely well organized. : : The presentations were informative and entertaining. One of the best meetings I’ve attended! : : Excellent program that brings cardiology and cardiac surgery together. : : A well-deserved reputation for a high-quality program! : : An outstanding program on cutting-edge subjects presented in a manner that invites active participation. What They’re Saying: 24TH Annual Meeting of the California ACC The Beverly Hills Hotel – Beverly Hills, California The Thirteenth in the Series • November 21 & 22, 2013 in the Treatment of Cardiovascular Disease Controversies & Advances Carlsbad, CA 92008 300 Carlsbad Village Dr., Suite 108A-326 Promedica International San Diego CA Permit 1948 Paid U.S. Postage Presort Standard